Clinical Trials
4 trialsNCT04562558 2025-08-11
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia
Peking Union Medical College Hospital
Phase NA Active not recruiting
NCT02664961 2019-07-23
Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
Tracon Pharmaceuticals Inc.
Phase 2 Terminated
NCT00475956 2010-04-15
Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed
NCT00190918 2007-08-09
A Trial for Patients With Gestational Trophoblastic Disease
Eli Lilly and Company
Phase 2 Completed